Annual core operating profit increased in 2024 for British pharmaceutical company GSK compared to 2023, the company reported ...
CHELMSFORD, MASSACHUSETTS / ACCESS Newswire / January 28, 2025 / Harte Hanks, Inc. , a pioneer in data-driven customer experience solutions that has been transforming how companies connect with their ...
CHELMSFORD, MASSACHUSETTS / ACCESS Newswire / January 28, 2025 / Harte Hanks, Inc. (NASDAQ:HHS), a pioneer in data-driven customer experience solutions that has been transforming how companies connect ...
CHELMSFORD, MASSACHUSETTS / ACCESS Newswire / January 28, 2025 / Harte Hanks, Inc. (NASDAQ:HHS), a pioneer in data-driven customer experience solutions that has been transforming how companies ...
To this end, the company revamped its logo (it’s now purple), adopted ... Ten, or 20 years ago, nobody would have even known that GlaxoSmithKline had undergone a rebrand, but now it’s very ...
Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...
UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.80. The company’s ...
The Connecticut company’s long-lived logo is now getting a new look tailored for the future and the dramatic shift to digital ...
Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...
AstraZeneca continued to see strong growth in 2024 on the back of a series of positive trials, as well as a solid pipeline of products.
The report provides insights into GSK's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) ...